BioWorld

April 16, 2003

View Archived Issues

Tumor Cells Lurk In Transplanted Organ, Wreak Kaposi's Sarcoma, Frequent Transplant Malignancy

Read More

Third Acadia, Allergan Deal Has Potential For More Than $32M

Read More

Biotech, Pharma Companies Continue Refining Relationships

Read More

International Consortium Finishes Full Sequence Of Human Genome

Read More

CancerVax Resuming Phase III Trials Of Canvaxin In Melanoma

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

GenVec Plans Merger With Diacrin Through $40M Stock Transaction

Not to compare the biotechnology industry - with its blockbuster drugs and groundbreaking science - with a flea market, but there are good deals in this depressed environment if you look around. (BioWorld Today) Read More

Sequencing Headway On SARS Could Lead To Critical Vaccine

Read More